ABSTRACT
Cell growth is driven by the acquisition and synthesis of both dry biomass and water mass. In this study, we examine the increase of water mass in T cell during cell growth. We found that T-cell growth is characterized by an initial phase of slow increase in cellular water, followed by a second phase of rapid increase in water content. To study the origin of the water gain, we developed a novel methodology we call cold aqua trap-isotope ratio mass spectrometry, which allows analysis of the isotope composition of intracellular water. Applying cold aqua trap-isotope ratio mass spectrometry, we discovered that glycolysis-coupled metabolism of water accounts on average for 11 fl out of the 20 fl of water gained per cell during the initial slow phase. In addition, we show that at the end of the rapid phase before initiation of cell division, a water influx occurs, increasing the cellular water mass by threefold. Thus, we conclude that activated T cells switch from metabolizing water to rapidly taking up water from the extracellular medium prior to cell division. Our work provides a method to analyze cell water content as well as insights into the ways cells regulate their water mass.
Subject(s)
Cell Division , T-Lymphocytes , Water , Cell Division/physiology , Mass Spectrometry , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Water/metabolismABSTRACT
Aging leads to a gradual decline in physical activity and disrupted energy homeostasis. The NAD+-dependent SIRT6 deacylase regulates aging and metabolism through mechanisms that largely remain unknown. Here, we show that SIRT6 overexpression leads to a reduction in frailty and lifespan extension in both male and female B6 mice. A combination of physiological assays, in vivo multi-omics analyses and 13C lactate tracing identified an age-dependent decline in glucose homeostasis and hepatic glucose output in wild type mice. In contrast, aged SIRT6-transgenic mice preserve hepatic glucose output and glucose homeostasis through an improvement in the utilization of two major gluconeogenic precursors, lactate and glycerol. To mediate these changes, mechanistically, SIRT6 increases hepatic gluconeogenic gene expression, de novo NAD+ synthesis, and systemically enhances glycerol release from adipose tissue. These findings show that SIRT6 optimizes energy homeostasis in old age to delay frailty and preserve healthy aging.
Subject(s)
Energy Metabolism/genetics , Frailty/metabolism , Healthy Aging/metabolism , Longevity/genetics , Sirtuins/metabolism , Animals , Disease Models, Animal , Female , Frailty/genetics , Gene Expression Regulation/physiology , Gluconeogenesis/genetics , Glucose/metabolism , Healthy Aging/genetics , Humans , Liver/metabolism , Male , Mice , Mice, Transgenic , Sirtuin 1/genetics , Sirtuin 1/metabolism , Sirtuins/geneticsABSTRACT
Respiratory complex II (CII, succinate dehydrogenase, SDH) inhibition can induce cell death, but the mechanistic details need clarification. To elucidate the role of reactive oxygen species (ROS) formation upon the ubiquinone-binding (Qp) site blockade, we substituted CII subunit C (SDHC) residues lining the Qp site by site-directed mutagenesis. Cell lines carrying these mutations were characterized on the bases of CII activity and exposed to Qp site inhibitors MitoVES, thenoyltrifluoroacetone (TTFA) and Atpenin A5. We found that I56F and S68A SDHC variants, which support succinate-mediated respiration and maintain low intracellular succinate, were less efficiently inhibited by MitoVES than the wild-type (WT) variant. Importantly, associated ROS generation and cell death induction was also impaired, and cell death in the WT cells was malonate and catalase sensitive. In contrast, the S68A variant was much more susceptible to TTFA inhibition than the I56F variant or the WT CII, which was again reflected by enhanced ROS formation and increased malonate- and catalase-sensitive cell death induction. The R72C variant that accumulates intracellular succinate due to compromised CII activity was resistant to MitoVES and TTFA treatment and did not increase ROS, even though TTFA efficiently generated ROS at low succinate in mitochondria isolated from R72C cells. Similarly, the high-affinity Qp site inhibitor Atpenin A5 rapidly increased intracellular succinate in WT cells but did not induce ROS or cell death, unlike MitoVES and TTFA that upregulated succinate only moderately. These results demonstrate that cell death initiation upon CII inhibition depends on ROS and that the extent of cell death correlates with the potency of inhibition at the Qp site unless intracellular succinate is high. In addition, this validates the Qp site of CII as a target for cell death induction with relevance to cancer therapy.
Subject(s)
Electron Transport Complex II/physiology , Ubiquinone/genetics , Ubiquinone/metabolism , Amino Acid Sequence , Binding Sites , Cell Death/physiology , Electron Transport Complex II/chemistry , Electron Transport Complex II/genetics , Electron Transport Complex II/metabolism , Humans , Mitochondria/metabolism , Mitochondria/physiology , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Conformation , Ubiquinone/chemistryABSTRACT
Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis. Here we show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1ß but not tumour-necrosis factor-α in mouse macrophages. A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows upregulation of glycolytic and downregulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites. Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate. Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (γ-aminobutyric acid) shunt' pathway also has a role. Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1α, an effect that is inhibited by 2-deoxyglucose, with interleukin-1ß as an important target. Lipopolysaccharide also increases succinylation of several proteins. We therefore identify succinate as a metabolite in innate immune signalling, which enhances interleukin-1ß production during inflammation.
Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Interleukin-1beta/biosynthesis , Signal Transduction , Succinic Acid/metabolism , Animals , Bone Marrow Cells/cytology , Citric Acid Cycle/drug effects , Deoxyglucose/pharmacology , Down-Regulation/drug effects , Genes, Mitochondrial/drug effects , Genes, Mitochondrial/genetics , Glutamine/metabolism , Glycolysis/drug effects , Glycolysis/genetics , Humans , Immunity, Innate/drug effects , Inflammation/metabolism , Interleukin-1beta/genetics , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mice , Up-Regulation/drug effects , gamma-Aminobutyric Acid/metabolismABSTRACT
Hypoxia-inducible factor (HIF) prolyl hydroxylases (PHDs) are α-ketoglutarate (αKG)-dependent dioxygenases that function as cellular oxygen sensors. However, PHD activity also depends on factors other than oxygen, especially αKG, a key metabolic compound closely linked to amino-acid metabolism. We examined the connection between amino-acid availability and PHD activity. We found that amino-acid starvation leads to αKG depletion and to PHD inactivation but not to HIF stabilization. Furthermore, pharmacologic or genetic inhibition of PHDs induced autophagy and prevented mammalian target of rapamycin complex 1 (mTORC1) activation by amino acids in a HIF-independent manner. Therefore, PHDs sense not only oxygen but also respond to amino acids, constituting a broad intracellular nutrient-sensing network.
Subject(s)
Amino Acids/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Procollagen-Proline Dioxygenase/metabolism , Animals , Cell Line , Enzyme Activation , Humans , Ketoglutaric Acids/metabolism , Mechanistic Target of Rapamycin Complex 1 , Mice , Models, Biological , Multiprotein Complexes/antagonists & inhibitors , Multiprotein Complexes/metabolism , Procollagen-Proline Dioxygenase/antagonists & inhibitors , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/metabolismABSTRACT
In 2009, the Nomenclature Committee on Cell Death (NCCD) proposed a set of recommendations for the definition of distinct cell death morphologies and for the appropriate use of cell death-related terminology, including 'apoptosis', 'necrosis' and 'mitotic catastrophe'. In view of the substantial progress in the biochemical and genetic exploration of cell death, time has come to switch from morphological to molecular definitions of cell death modalities. Here we propose a functional classification of cell death subroutines that applies to both in vitro and in vivo settings and includes extrinsic apoptosis, caspase-dependent or -independent intrinsic apoptosis, regulated necrosis, autophagic cell death and mitotic catastrophe. Moreover, we discuss the utility of expressions indicating additional cell death modalities. On the basis of the new, revised NCCD classification, cell death subroutines are defined by a series of precise, measurable biochemical features.
Subject(s)
Apoptosis , Autophagy , Cells/metabolism , Cells/pathology , Necrosis , Terminology as Topic , Animals , Caspases/metabolism , Humans , MitosisABSTRACT
Caspase-8 stably inserts into the mitochondrial outer membrane during extrinsic apoptosis. Inhibition of caspase-8 enrichment on the mitochondria impairs caspase-8 activation and prevents apoptosis. However, the function of active caspase-8 on the mitochondrial membrane remains unknown. In this study, we have identified a native complex containing caspase-8 and BID on the mitochondrial membrane, and showed that death receptor activation by Fas or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced the cleavage of BID (tBID formation) within this complex. tBID then shifted to separate mitochondria-associated complexes that contained other BCL-2 family members, such as BAK and BCL-X(L). We report that cells stabilize active caspase-8 on the mitochondria in order to specifically target mitochondria-associated BID, and that BID cleavage on the mitochondria is essential for caspase-8-induced cytochrome c release. Our findings indicate that during extrinsic apoptosis, caspase-8 can specifically target BID where it is mostly needed, on the surface of mitochondria.
Subject(s)
BH3 Interacting Domain Death Agonist Protein/metabolism , Caspase 8/metabolism , Mitochondrial Membranes/metabolism , Cell Death/drug effects , Cytochromes c/metabolism , Green Fluorescent Proteins/metabolism , HeLa Cells , Humans , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondrial Membranes/drug effects , Mitochondrial Proteins/metabolism , Models, Biological , Molecular Weight , Mutant Proteins/metabolism , Peptide Elongation Factor Tu/metabolism , Point Mutation/genetics , Protein Binding/drug effects , Protein Transport/drug effects , Recombinant Proteins/pharmacology , TNF-Related Apoptosis-Inducing Ligand/pharmacology , fas Receptor/metabolismABSTRACT
Cells exposed to low-oxygen conditions (hypoxia) alter their metabolism to survive. This response, although vital during development and high-altitude survival, is now known to be a major factor in the selection of cells with a transformed metabolic phenotype during tumorigenesis. It is thought that hypoxia-selected cells have increased invasive capacity and resistance to both chemo- and radiotherapies, and therefore represent an attractive target for antitumor therapy. Hypoxia inducible factors (HIFs) are responsible for the majority of gene expression changes under hypoxia, and are themselves controlled by the oxygen-sensing HIF prolyl hydroxylases (PHDs). It was previously shown that mutations in succinate dehydrogenase lead to the inactivation PHDs under normoxic conditions, which can be overcome by treatment with alpha-ketoglutarate derivatives. Given that solid tumors contain large regions of hypoxia, the reactivation of PHDs in these conditions could induce metabolic catastrophe and therefore prove an effective antitumor therapy. In this report we demonstrate that derivatized alpha-ketoglutarate can be used as a strategy for maintaining PHD activity under hypoxia. By increasing intracellular alpha-ketoglutarate and activating PHDs we trigger PHD-dependent reversal of HIF1 activation, and PHD-dependent hypoxic cell death. We also show that derivatized alpha-ketoglutarate can permeate multiple layers of cells, reducing HIF1alpha levels and its target genes in vivo.
Subject(s)
Hypoxia-Inducible Factor 1/metabolism , Procollagen-Proline Dioxygenase/metabolism , Animals , Cell Death/physiology , Cell Hypoxia/physiology , Enzyme Activation , Female , HCT116 Cells , Humans , Hypoxia-Inducible Factor 1/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Hypoxia-Inducible Factor-Proline Dioxygenases , Ketoglutaric Acids/metabolism , Ketoglutaric Acids/pharmacology , Metabolic Networks and Pathways , Mice , Mice, Inbred BALB C , Mice, Nude , Oxygen/metabolism , Transfection , Von Hippel-Lindau Tumor Suppressor Protein/metabolismABSTRACT
The phenomenon of enhanced glycolysis in tumours has been acknowledged for decades, but biochemical evidence to explain it is only just beginning to emerge. A significant hint as to the triggers and advantages of enhanced glycolysis in tumours was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tumour suppressors and which associated, for the first time, mitochondrial enzymes and their dysfunction with tumorigenesis. Further steps forward showed that the substrates of SDH and FH, succinate and fumarate, respectively, can mediate a 'metabolic signalling' pathway. Succinate or fumarate, which accumulate in mitochondria owing to the inactivation of SDH or FH, leak out to the cytosol, where they inhibit a family of prolyl hydroxylase enzymes (PHDs). Depending on the PHD inhibited, two newly recognized pathways that support tumour maintenance may ensue: affected cells become resistant to certain apoptotic signals and/or activate a pseudohypoxic response that enhances glycolysis and is conveyed by hypoxia-inducible factor.
Subject(s)
Fumarate Hydratase/genetics , Mitochondria/physiology , Neoplasms/physiopathology , Succinate Dehydrogenase/genetics , Genes, Tumor Suppressor , Humans , Mitochondria/enzymology , Neoplasms/enzymologyABSTRACT
During apoptosis, the mitochondrial membrane potential (MMP) decreases, but it is not known how this relates to the apoptotic process. It was recently suggested that cytochrome c is compartmentalized in closed cristal regions and therefore, matrix remodeling is required to attain complete cytochrome c release from the mitochondria. In this work we show that, at the onset of apoptosis, changes in MMP control matrix remodeling prior to cytochrome c release. Early after growth factor withdrawal the MMP declines and the matrix condenses. Both phenomena are reversed by adding oxidizable substrates. In mitochondria isolated from healthy cells, matrix condensation can be induced by either denying oxidizable substrates or by protonophores that dissipate the membrane potential. Matrix remodeling to the condensed state results in cristal unfolding and exposes cytochrome c to the intermembrane space facilitating its release from the mitochondria during apoptosis. In contrast, when a transmembrane potential is generated due to either electron transport or a pH gradient formed by acidifying the medium, mitochondria maintain an orthodox configuration in which most cytochrome c is sequestered in the cristae and is resistant to release by agents that disrupt the mitochondrial outer membrane.
Subject(s)
Apoptosis/physiology , Carbonyl Cyanide m-Chlorophenyl Hydrazone/analogs & derivatives , Cytochromes c/metabolism , Cytosol/metabolism , Intracellular Membranes/metabolism , Mitochondria/metabolism , Animals , Apoptosis/drug effects , Benzamides/pharmacology , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Cell Line , Cell Respiration/drug effects , Cell Respiration/physiology , Cytosol/drug effects , Cytosol/ultrastructure , Immunohistochemistry , Interleukin-3/deficiency , Intracellular Membranes/drug effects , Intracellular Membranes/ultrastructure , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Microscopy, Electron , Mitochondria/drug effects , Mitochondria/ultrastructure , Peptides/pharmacology , Rotenone/pharmacology , Succinates/pharmacologySubject(s)
Orthodontics/economics , Practice Management, Dental/economics , Adult , Child , Efficiency, Organizational , Fees, Dental , Humans , Income , Marketing of Health Services , Orthodontics/organization & administration , Patient Care Planning/economics , Patient Care Planning/organization & administration , Personnel Management , Practice Management, Dental/organization & administration , Time Factors , United StatesSubject(s)
Orthodontics/economics , Orthodontics/statistics & numerical data , Practice Management, Dental/statistics & numerical data , Practice Patterns, Dentists'/statistics & numerical data , Humans , Income/statistics & numerical data , Orthodontics/organization & administration , Orthodontics/trends , Practice Management, Dental/economics , Professional Practice Location/statistics & numerical data , Referral and Consultation/statistics & numerical data , United StatesABSTRACT
The Bcl-2 family of proteins are involved in regulating the redox state of cells. However, the mode of action of Bcl-2 proteins remains unclear. This work analyzed the effects of Bcl-x(L) on the cellular redox state after treatment with tumor necrosis factor alpha (TNF-alpha) or exogenous oxidants. We show that in cells that undergo TNF-alpha-induced apoptosis, TNF-alpha induces a partial decrease in mitochondrial membrane potential (DeltaPsi(m)) followed by high levels of reactive oxygen species (ROS). ROS scavengers delay the progression of mitochondrial depolarization and apoptotic cell death. This indicates that ROS are important mediators of mitochondrial depolarization. However, ROS scavengers fail to prevent the initial TNF-alpha-induced decrease in DeltaPsi(m). In contrast, expression of Bcl-x(L) prevents both the initial decrease in DeltaPsi(m) following TNF-alpha treatment and the subsequent induction of ROS. Bcl-x(L) itself does not act as a ROS scavenger. In addition, Bcl-x(L) does not block the initial decrease in DeltaPsi(m) following treatment with the oxidant hydrogen peroxide. However, unlike control-transfected cells, Bcl-x(L)-expressing cells can recover their mitochondrial membrane potential following the initial drop in DeltaPsi(m) induced by hydrogen peroxide. These data suggest that Bcl-x(L) plays a regulatory role in controlling the membrane potential of and ROS production by mitochondria rather than acting as a direct antioxidant.
Subject(s)
Apoptosis/physiology , Membrane Potentials , Mitochondria/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Animals , Antioxidants/metabolism , Apoptosis/drug effects , Cell Polarity , Cell Respiration/drug effects , Hybridomas , Hydrogen Peroxide/pharmacology , Intracellular Membranes/metabolism , Mice , Oxidants/pharmacology , T-Lymphocytes/drug effects , Tumor Necrosis Factor-alpha/metabolism , bcl-X ProteinABSTRACT
Any statement about the ability of the specialty to meet the future demand for orthodontic care based merely on a ratio of the projected number of orthodontists to the projected population is an oversimplification. Still, some inferences can be drawn from the data presented in this article. To be as prudent as possible, we will limit the scope of the discussion to the next 10 years. 1. It seems likely that the annual number of orthodontic graduates will remain about the same. 2. Considering the slow increase in the average age of orthodontists, the death rate will increase slightly, but not significantly. 3. The average annual number of retirees will be somewhere between 125 (the current rate) and 359 (the maximum projected by the JCO Retirement Survey). 4. The above assumptions would leave no less than 7,500 practicing orthodontists in the United States in 10 years. 5. The number of children age 9-17 will increase by 5-10%. In a worst-case scenario, could 7,500 orthodontists meet the orthodontic demand 10 years from now? The 1997 JCO Orthodontic Practice Study reported the annual median number of case starts to be 180. Multiplied by 9,000 orthodontists, that would equal 1,620,000 case starts. If we project a 10% increase in demand, there could be 1,782,000 case starts 10 years from now--an average of 238 starts per year for 7,500 orthodontists. Respondents to the Practice Studies have consistently indicated that they could handle 50 additional case starts with no increase in staff or facilities, which would mean current orthodontists could accommodate an average of 230 case starts. Moreover, orthodontic productivity is likely to increase due to delegation and improved technology. In conclusion, even if the sharp increase in the number of annual retirements anticipated in the JCO Retirement Survey turns out to be correct, it seems unlikely that it will affect the ability of the specialty to accomplish its mission in the foreseeable future.